Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Hand Surg Rehabil ; 38(1): 28-33, 2019 02.
Article in English | MEDLINE | ID: mdl-30509732

ABSTRACT

We compared post-operative distal radius fracture (DRF) displacement after volar locking plate fixation using full-length unicortical and shorter-length distal locking screws. In this non-inferiority, retrospective cohort study, DRFs treated with volar locking plate fixation were evaluated on X-rays. In the full-length group, volar locking plate fixation was performed with full-length unicortical distal locking screws. In the shorter-length group, the distal locking screws were planned pre-operatively to be approximately 75% of the distal radius depth based on the lunate depth, and the same depth was drilled. Three radiographic parameters - ulnar variance, volar tilt, and radial inclination - were measured intra-operatively and at the final follow-up. The displacements were compared between the two groups. Each group contained 34 fractures. The mean ulnar variance between the two periods increased 1.1 mm in the full-length group and 1.3 mm in the shorter group (mean difference, 0.2 mm; 90% confidence interval, -0.3 to 0.6). The shorter group was not significantly inferior to the full-length one. Volar tilt increased 0.6° in the full-length group and -0.1° in the shorter group, while the radial inclination increased 0.1° in the full-length group and 0.2° in the shorter one. The differences in the increases were not significant. The post-operative DRF stability of 75%-length distal locking screws was not inferior to that of full-length unicortical screws. To prevent extensor pollicis longus tendon rupture, shorter distal locking screws and the same drilling depth may be preferable for volar locking plate fixation.


Subject(s)
Bone Plates , Bone Screws , Fracture Fixation, Internal/instrumentation , Radius Fractures/diagnostic imaging , Radius Fractures/surgery , Aged , Cohort Studies , Female , Humans , Male , Prosthesis Design , Radiography , Retrospective Studies
2.
Theor Appl Genet ; 124(5): 937-46, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22113591

ABSTRACT

Low temperature at the booting stage of rice causes male sterility resulting in severe yield loss. Cold tolerance has long been an important objective in rice breeding. We identified a quantitative trait locus (QTL) for cold tolerance on the long arm of chromosome 3 from the cold-tolerant breeding line 'Ukei 840' by using F(2) and BC(1)F(2) populations from crosses between 'Ukei 840' and 'Hitomebore'. The cold tolerance of 'Ukei 840' is derived from the Chinese cultivar 'Lijiangxintuanheigu'. The effect of this QTL on cold tolerance was confirmed by developing 'Hitomebore' chromosome segment substitution lines having 'Lijiangxintuanheigu' alleles on chromosome 3. By producing recombinants in chromosome 3, the QTL region for cold tolerance was delimited to the region of about 1.2-Mb region between RM3719 and RM7000. All lines heterozygous for the QTL showed seed fertilities as low as that of 'Hitomebore', suggesting that the 'Lijiangxintuanheigu' allele for cold tolerance in the QTL region is recessive. Determination of a 1.2-Mb nucleotide sequence of 'Ukei 840' and comparison with the published genomic sequence of 'Nipponbare' showed 254 SNPs, of which 11 were in coding regions of genes, seven in five genes being non-synonymous. SNPs were detected in the 5-kb upstream regions of 89 genes, but no differences of gene expression levels were detected between alleles of these genes. Although further delimitation is required to identify the gene responsible for cold tolerance of 'Lijiangxintuanheigu', SNP markers developed here will be useful for marker-assisted selection in a breeding program using 'Lijiangxintuanheigu' as a donor of cold tolerance.


Subject(s)
Adaptation, Biological/genetics , Breeding/methods , Cold Temperature , Oryza/genetics , Quantitative Trait Loci/genetics , Genes, Recessive/genetics , Genetic Markers/genetics , Genotype , Reverse Transcriptase Polymerase Chain Reaction , Selection, Genetic , Sequence Analysis, DNA
3.
Parkinsonism Relat Disord ; 16(7): 447-52, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20472488

ABSTRACT

Patients with idiopathic Parkinson's disease (PD) appear to have reduced capacity for detoxification of certain environmental compounds. The glutathione S-transferases (GSTs) are candidate genes for PD because they are involved in the metabolism of pesticides and cigarette smoke. We investigated the relationship of the seven GST polymorphisms (GSTM1 deletion, GSTT1 deletion, GSTP1 rs1695, GSTO1 rs4925, GSTO1 rs11191972, GSTO2 rs156697 and GSTO2 rs2297235) and PD risk with special reference to the interaction with pesticide use or cigarette smoking among 238 patients with PD cases and 370 controls in a Japanese population. None of the GST polymorphisms were associated with PD. GSTO1 rs4925 and GSTO2 rs2297235 were found to be in strong linkage disequilibrium (D' = 0.98). Cigarette smoking was significantly associated with decreased risk of PD. However, no interaction of smoking with any of the GST polymorphisms was observed. Self-reported pesticide use was not associated with increased risk of PD. There was no evidence of interaction between self-reported pesticide use and either GST polymorphism. Our results suggest that the tested GST polymorphisms did not play an important role in PD susceptibility in our Japanese population. Our study does not give evidence of interaction between the GST polymorphisms and smoking may although this study provided sufficient statistical power to detect modest interaction. As for interaction between GSTP polymorphisms and pesticide use, the power of this study to detect an interactive effect was low due to a small number of pesticide users. Future studies involving larger control and case populations and better pesticide exposure histories will undoubtedly lead to a more thorough understanding of the role of the GST polymorphisms in PD development.


Subject(s)
Glutathione Transferase/genetics , Parkinson Disease , Pesticides/adverse effects , Polymorphism, Genetic/genetics , Smoking , Aged , Environmental Exposure/adverse effects , Female , Genome-Wide Association Study , Genotype , Humans , Japan/epidemiology , Male , Middle Aged , Odds Ratio , Parkinson Disease/etiology , Parkinson Disease/genetics , Parkinson Disease/psychology , Population Groups , Retrospective Studies , Risk Factors
4.
J Hum Genet ; 53(4): 314-324, 2008.
Article in English | MEDLINE | ID: mdl-18259684

ABSTRACT

To systematically evaluate genetic susceptibility to type 2 diabetes (T2D) in "candidate" regions on chromosomes 1q, 3q and 12q, we examined disease association by using a total of 2,083 SNPs in two-step screening; a screening panel comprised 473 cases and 285 controls and an extended (or combined) panel involved 658 cases and 474 controls. For the total interval screened (40.9 Mb), suggestive evidence of association was provided for several annotated gene loci. For example, in the MCF2L2 gene on 3q, a significant association (a nominal P value of 0.00009) was observed when logistic regression analysis was performed for three associated SNPs (rs684846, rs35069869 and rs35368790) that belonged to different LD groups. Also, in the SLC15A4 gene on 12q, rs3765108 showed a marginally significant association with an overall estimated odds ratio of 0.79 (P=0.001). No significant association was found for known candidate gene loci on 3q, such as ADIPOQ and IGF2BP2. Using the available samples, we have observed disease associations of SNPs derived from two novel gene loci in the Japanese population through high-density searches of diabetes susceptibility in three chromosomal regions. Independent replication will clarify the etiological relevance of these genomic loci to T2D.


Subject(s)
Asian People/genetics , Chromosomes, Human, Pair 12/genetics , Chromosomes, Human, Pair 1/genetics , Chromosomes, Human, Pair 3/genetics , Diabetes Mellitus, Type 2/genetics , Genetic Predisposition to Disease/genetics , Carrier Proteins/genetics , Humans , Japan , Linkage Disequilibrium , Lod Score , Logistic Models , Membrane Transport Proteins , Nerve Tissue Proteins/genetics , Polymorphism, Single Nucleotide
5.
Oncogene ; 27(26): 3729-38, 2008 Jun 12.
Article in English | MEDLINE | ID: mdl-18223682

ABSTRACT

Antiangiogenic therapies are promising approaches to cancer control, but the details of their effects on subsequent tumor progression are not fully understood. Such therapies have the potential to eventually generate extensive amounts of tumor ischemia, and we previously demonstrated that ischemic conditions induce K-ras mutations in cells with deficient mismatch repair (MMR) mechanisms. This suggested that similar effects on oncogene mutagenesis may accompany antiangiogenic therapy. To test this, MMR-deficient colorectal cancer cells (Dks-8) were xenografted into immune-deficient mice and treated with the antiangiogenic regimen of low-dose/metronomic cyclophosphamide for 2 weeks followed by a 2-week recovery period without therapy. This treatment resulted in transient tumor growth inhibition, increased hypoxia, and decreased microvessel density, and cancer cells from treated tumors acquired activating mutations of the K-ras oncogene (K-ras(G13D)). In vitro exposure of Dks-8 cells to the active metabolite of cyclophosphamide (4-hydroxycyclophosphamide) had no effect on the K-ras status, indicating that there was no direct action of this alkylating agent on K-ras mutagenesis. In addition, cells sorted from hypoxic regions of Dks-8 tumors were enriched in K-ras(G13D) mutants. Collectively, our studies suggest that increases in tumor hypoxia induced by antiangiogenic treatment may lead to K-ras mutation and consequently tumor progression, especially in susceptible individuals.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Cell Hypoxia , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/genetics , Cyclophosphamide/therapeutic use , Genes, ras , Mutation , Animals , Cell Line, Tumor , Colorectal Neoplasms/blood supply , Colorectal Neoplasms/metabolism , Cyclophosphamide/analogs & derivatives , Humans , Mice , Neoplasm Transplantation , Transplantation, Heterologous
6.
Biochem Biophys Res Commun ; 357(4): 1100-6, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17466274

ABSTRACT

Significant evidence of linkage to type 2 diabetes (T2D) has been shown in a relatively broad region on chromosome 20q, where the hepatocyte nuclear factor-4alpha (HNF4A) has been noted as a positional candidate. To systematically evaluate genetic susceptibility to T2D in the relevant region, we examined the disease association by using 1145 SNPs in two-step screening in the Japanese population. The marker screening enabled us to identify significant disease association in the lipopolysaccharide binding protein (LBP) but not in the HNF4A locus. In a 17.7-Mb interval screened, the strongest association was identified for a SNP, rs2232592, located in the intron of LBP, with an estimated odds ratio of 1.73 (95% CI 1.30-2.31) (P=0.0002) in the whole study panel involving 675 case and 474 control subjects. Our data suggest that the LBP gene may confer genetic susceptibility to T2D and this warrants further replication study.


Subject(s)
Acute-Phase Proteins/genetics , Carrier Proteins/genetics , Chromosomes, Human, Pair 20/genetics , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/genetics , Hepatocyte Nuclear Factor 4/genetics , Membrane Glycoproteins/genetics , Aged , Aged, 80 and over , DNA Mutational Analysis/methods , Female , Genetic Predisposition to Disease/epidemiology , Genetic Predisposition to Disease/genetics , Humans , Japan/epidemiology , Male , Middle Aged , Polymorphism, Single Nucleotide/genetics , Prevalence
7.
Oncogene ; 26(14): 2071-81, 2007 Mar 29.
Article in English | MEDLINE | ID: mdl-17016440

ABSTRACT

Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of prostaglandins, promotes the development of colorectal cancer, and is a key molecular target of non-steroidal anti-inflammatory drugs, compounds that reduce the relative risk of developing colon cancer. In this study, we showed that interferon gamma (IFNgamma) inhibits the expression of COX-2 protein in intestinal epithelial cells (IECs) through a pathway that requires Janus-activated kinase (JAK) activity. In contrast, we demonstrated that transcriptional inhibition of COX-2 by IFNbeta or IFNgamma occurs in cells with silenced signal transducer and activator of transcription 1 (STAT1) expression and that IFNs retained the ability to inhibit COX-2 transcription in cells with activated RasV12, in which IFNgamma failed to induce STAT1. Thus, unlike the activity of JAK, STAT1 is not required for the inhibition of COX-2 expression by IFNgamma. In contrast to COX-2, the activation of genes in response to IFNgamma, such as interferon regulatory factor-1, was severely impaired by both STAT1 silencing and by constitutive Ras signaling. To determine whether there is a general differential requirement for STAT1 in gene activation and gene repression in response to IFNgamma in intestinal cells, we performed genome-wide analysis of IFNgamma target genes in an IEC line in which STAT1 expression was silenced by small interfering RNA. The results confirmed that the activation of the majority of genes by IFNgamma required STAT1. In contrast, the repression of several genes, as we showed for COX-2 specifically, was largely unaffected in cells with silenced STAT1. Our results therefore demonstrate that in general gene activation by IFNgamma is more sensitive to STAT1 deficiency than gene repression, and suggest that IFNgamma activates and represses gene expression via distinct pathways that can be distinguished, at least in part, by their requirement for STAT1.


Subject(s)
Cyclooxygenase 2/genetics , Down-Regulation , Gene Expression/drug effects , Interferon-gamma/pharmacology , STAT1 Transcription Factor/metabolism , Cells, Cultured , Cyclooxygenase 2/metabolism , Gene Silencing , Humans , Intestinal Mucosa/drug effects , Intestinal Mucosa/enzymology , Janus Kinases/metabolism , Oligonucleotide Array Sequence Analysis , Protein Biosynthesis/drug effects , RNA, Small Interfering/pharmacology , STAT1 Transcription Factor/antagonists & inhibitors , STAT1 Transcription Factor/genetics , Transcriptional Activation
8.
Oncogene ; 25(59): 7680-90, 2006 Dec 14.
Article in English | MEDLINE | ID: mdl-16799641

ABSTRACT

Detachment of normal epithelial cells from the extracellular matrix triggers apoptosis, a phenomenon called anoikis. Conversely, carcinoma cells tend to be relatively more anoikis-resistant than their normal counterparts, and this increased resistance represents a critical feature of the malignant phenotype. Mechanisms that control susceptibility and resistance to anoikis are not fully understood. It is now known that detachment of non-malignant epithelial cells triggers both pro- and antiapoptotic signals, and it is the balance between these signals and the duration of detachment that determine further fate of the cells. Detachment-induced antiapoptotic events delay anoikis and if cells reattach relatively soon after detachment they survive. Direct regulators of apoptosis responsible for this delay of anoikis are unknown. We found that detachment of non-malignant intestinal epithelial cells triggers upregulation of inhibitors of apoptosis protein (IAP) family, such as X-chromosome-linked inhibitor of apoptosis protein and cellular inhibitor of apoptosis-2 (cIAP2). We demonstrated that this upregulation requires detachment-dependent activation of the transcription factor nuclear factor-kappaB. We further observed that various IAP antagonists accelerate anoikis, indicating that upregulation of the IAPs delays detachment-triggered apoptosis. We conclude that the IAPs are important regulators of the balance between detachment-triggered life and death signals. Perhaps, not by coincidence, these proteins are often upregulated in carcinomas, tumors composed of cells that tend to be anoikis-resistant.


Subject(s)
Anoikis , Inhibitor of Apoptosis Proteins/physiology , Intestinal Mucosa/pathology , X-Linked Inhibitor of Apoptosis Protein/physiology , Baculoviral IAP Repeat-Containing 3 Protein , Cells, Cultured , Extracellular Matrix/physiology , Humans , Inhibitor of Apoptosis Proteins/antagonists & inhibitors , Inhibitor of Apoptosis Proteins/genetics , NF-kappa B/physiology , Ubiquitin-Protein Ligases , Up-Regulation , X-Linked Inhibitor of Apoptosis Protein/antagonists & inhibitors , X-Linked Inhibitor of Apoptosis Protein/genetics , bcl-X Protein/genetics , bcl-X Protein/physiology
9.
Tissue Antigens ; 64(5): 600-7, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15496204

ABSTRACT

In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS-CoV) epitope peptides capable of inducing long-lasting immunity, we first screened immunoglobulin-G (IgG) antibodies reactive to 197 different overlapping 15-mers from the SARS-CoV proteins in the sera of three infected patients. Forty-two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6-month post-infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post-infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long-lasting immunity, may provide a better understanding of the immunogenicity of SARS-CoV.


Subject(s)
Immune System/immunology , Immunity/immunology , Peptides/immunology , Severe acute respiratory syndrome-related coronavirus/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/blood , Rheology , Serum/immunology
10.
Genes Dev ; 15(19): 2533-45, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11581159

ABSTRACT

Brainstem visceral sensory and (nor)adrenergic neurons play crucial roles in modulating cardiovascular and respiratory functions. The origins and formation of these neurons are poorly understood. Here we show that these two classes of neurons are derived from Mash1-positive precursor cells, and can be prospectively identified by combinatorial expression of two homeobox genes, Rnx and Phox2 (Phox2a or Phox2b). It was previously shown that Rnx-deficient mice die from respiratory failure. Here we show that Rnx function is required for formation of first-order relay visceral sensory neurons in the brainstem. In addition, as in Phox2b-deficient mice, the development of most (nor)adrenergic centers is compromised in Rnx mutants. We also provide genetic evidence to show that Rnx and Phox2 proteins may function independently to specify the (nor)adrenergic phenotype. Our studies reveal a surprising ontogenetic relationship between relay visceral sensory and (nor)adrenergic neurons, and suggest that it may be a common theme in the developing nervous system that the same set of transcriptional regulators is associated with formation of multiple components within a neuronal network.


Subject(s)
Brain Stem/metabolism , Homeodomain Proteins/metabolism , Neurons, Afferent/metabolism , Norepinephrine/metabolism , Oncogene Proteins/metabolism , Receptors, Adrenergic/metabolism , Animals , Base Sequence , DNA Primers , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Mice , Mice, Mutant Strains , Oncogene Proteins/genetics , Transcription Factors/genetics , Transcription Factors/metabolism
11.
Kyobu Geka ; 54(9): 742-6, 2001 Aug.
Article in Japanese | MEDLINE | ID: mdl-11517542

ABSTRACT

A 58-year-old female was admitted to the hospital complaining of dyspnea. The chest roentgenogram and CT scan revealed a large mediastinum tumor and massive pleural effusion in the right hemithorax. The diagnosis of lung cancer with carcinomatous pleulitis was performed through thoracocentesis an treatment of chemotherapy was chosen. After 6 years, she was admitted again to the hospital complaining of dull pain in the right leg. Chest CT scan and MRI showed a giant dumbbell shaped mass connected to the spinal canal. The tumor was larger than that of six years ago and diagnosed as schwannoma by CT-guided pericutaneous needle biopsy. At operation, hemilaminectomy of Th 1-3 was done first, and total tumor resection was performed through posterolateral thoracotomy. Intrathoracic adhesion was severe and it was difficult to control air leakage from the lung, thoracoplasty was performed.


Subject(s)
Mediastinal Neoplasms/complications , Neurilemmoma/complications , Pleural Effusion, Malignant/etiology , Female , Humans , Mediastinal Neoplasms/surgery , Middle Aged , Neurilemmoma/surgery
12.
Hum Mol Genet ; 10(13): 1379-86, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11440990

ABSTRACT

Autoimmune thyroid disease (AITD), including Graves' disease (GD) and Hashimoto's thyroiditis (HT), is caused by multiple genetic and environmental factors. The clinical and immunological features of GD and HT are distinct; however, there are multiplex families with both GD and HT, and cases in which GD evolves into HT. Thus, there may be specific susceptibility loci for GD or HT, and common loci controlling the susceptibility to both GD and HT may exist. A genome-wide analysis of data on 123 Japanese sib-pairs affected with AITD was made in which GD- or HT-affected sib-pairs (ASPs) were studied to detect GD- or HT-specific susceptibility loci, and all AITD-ASPs were used to detect AITD-common susceptibility loci. Our study revealed 19 regions on 14 chromosomes (1, 2, 3, 5, 6, 8, 9, 10, 11, 12, 13, 15, 18 and 22) where the multipoint maximum LOD score (MLS) was >1. Especially, chromosome 5q31-q33 yielded suggestive evidence for linkage to AITD as a whole, with an MLS of 3.14 at D5S436, and chromosome 8q23-q24 yielded suggestive evidence for linkage to HT, with an MLS of 3.77 at D8S272. These observations suggest the presence of an AITD susceptibility locus at 5q31-q33 and a HT susceptibility locus at 8q23-q24.


Subject(s)
Autoimmune Diseases/genetics , Chromosomes, Human, Pair 5/genetics , Chromosomes, Human, Pair 8/genetics , Genetic Predisposition to Disease/genetics , Immunoconjugates , Thyroid Diseases/genetics , Thyroiditis, Autoimmune/genetics , Abatacept , Antigens, CD , Antigens, Differentiation/genetics , CTLA-4 Antigen , Chromosome Mapping , Family Health , Female , Genetic Linkage , Graves Disease/genetics , HLA Antigens/genetics , Humans , Japan , Lod Score , Male , Microsatellite Repeats
14.
Cell ; 103(2): 321-30, 2000 Oct 13.
Article in English | MEDLINE | ID: mdl-11057904

ABSTRACT

Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19ARF. This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19ARF. Levels of p53 are therefore determined by opposing effects of Raf-induced p19ARF and Mdm2.


Subject(s)
Nuclear Proteins , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Tumor Suppressor Protein p53/metabolism , ras Proteins/metabolism , Animals , Base Sequence , Cell Line , Gamma Rays/adverse effects , Mice , Mice, Mutant Strains , Molecular Sequence Data , Mutagens/pharmacology , Mutation , Promoter Regions, Genetic , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-ets , Proto-Oncogene Proteins c-mdm2 , Proto-Oncogene Proteins c-raf/metabolism , Radiation Tolerance/genetics , Response Elements , Signal Transduction , Transcription Factor AP-1 , Transcription Factors/metabolism , Tumor Suppressor Protein p14ARF , ras Proteins/genetics
15.
Nat Genet ; 24(3): 287-90, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10700185

ABSTRACT

The genes Tlx1 (Hox11), Enx (Hox11L2, Tlx-2) and Rnx (Hox11L2, Tlx-3) constitute a family of orphan homeobox genes. In situ hybridization has revealed considerable overlap in their expression within the nervous system, but Rnx is singularly expressed in the developing dorsal and ventral region of the medulla oblongata. Tlx1-deficient and Enx-deficient mice display phenotypes in tissues where the mutated gene is singularly expressed, resulting in asplenogenesis and hyperganglionic megacolon, respectively. To determine the developmental role of Rnx, we disrupted the locus in mouse embryonic stem (ES) cells. Rnx deficient mice developed to term, but all died within 24 hours after birth from a central respiratory failure. The electromyographic activity of intercostal muscles coupled with the C4 ventral root activity assessed in a medulla-spinal cord preparation revealed a high respiratory rate with short inspiratory duration and frequent apnea. Furthermore, a coordinate pattern existed between the abnormal activity of inspiratory neurons in the ventrolateral medulla and C4 motorneuron output, indicating a central respiratory defect in Rnx mice. Thus, Rnx is critical for the development of the ventral medullary respiratory centre and its deficiency results in a syndrome resembling congenital central hypoventilation.


Subject(s)
Abnormalities, Multiple/genetics , Genes, Homeobox , Homeodomain Proteins/physiology , Hypoventilation/genetics , Oncogene Proteins/physiology , Animals , Apnea/congenital , Apnea/genetics , Cyanosis/genetics , Electromyography , Embryonic and Fetal Development/genetics , Genes, Lethal , Genotype , Gestational Age , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Hypoventilation/congenital , In Situ Hybridization , Intercostal Muscles/physiopathology , Medulla Oblongata/metabolism , Mice , Mice, Knockout , Motor Neurons/pathology , Neurons/pathology , Oncogene Proteins/deficiency , Oncogene Proteins/genetics , Oncogene Proteins/metabolism , Polycomb-Group Proteins , Repressor Proteins/genetics , Repressor Proteins/physiology , Respiratory Center/embryology , Respiratory Center/pathology , Spinal Cord/metabolism
16.
Shinrigaku Kenkyu ; 71(5): 403-7, 2000 Dec.
Article in Japanese | MEDLINE | ID: mdl-11247286

ABSTRACT

A study was conducted examine whether the asymmetric confusability effect was generalized to an array of face photographs, and furthermore to investigate how the impression of faces affected the recognition of addition and deletion of the faces. In a preliminary investigation, 27 subjects rated the impression of 83 face photographs, and the photographs to be used in the present study were chosen on the basis of the impression scores. In the study, 40 subjects saw 14 photographs consisted of three or four faces and took a recognition test of unchanged photographs and changed photographs with a specific face added or deleted. The data showed that (a) the addition superiority was not found in the recognition of changes in face arrays; (b) the impression of faces differentially affected the recognition of addition and deletion changes in face arrays. These results suggest that the mechanism underlying the recognition of the deletion of a face may be different from that of addition.


Subject(s)
Face , Recognition, Psychology/physiology , Adult , Female , Humans , Photic Stimulation , Photography
17.
Cancer Res ; 60(24): 6886-9, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11156386

ABSTRACT

To identify the genes located downstream of the activated Ki-Ras signaling pathways in human colon cancer cells, a PCR-based cDNA subtraction library was constructed between HCT116 cells and HCT116-derived activated Ki-ras-disrupted cells (HKe3). One of the genes in HCT116 that was evidently up-regulated was epiregulin, a member of the epidermal growth factor family that is expressed in many kinds of human cancer cells. HKe3-stable transfectants expressing activated Ki-Ras regained over-expression of epiregulin. To further elucidate the biochemical structure and significance of epiregulin expression in tumorigenesis, HKe3-stable transfectants expressing epiregulin (e3-pSE cells) were established. Epiregulin existed as highly glycosylated membrane-bound forms, and TPA rapidly induced ectodomain shedding of epiregulin. Furthermore, the conditioned medium of e3-pSE cells showed more DNA synthesis for 32D cells expressing epidermal growth factor receptor (DER) cells than that of HKe3. Although anchorage-independent growth in soft agar was not observed for e3-pSE cells, tumorigenicity in nude mice was observed evidently, and their growth rate was correlated with each amount of exogenous epiregulin expression. These results suggested that activated Ki-Ras will be one of the factors contributing to the overexpression of epiregulin in human colon cancer cells, and that epiregulin will play a critical role in human tumorigenesis in vivo.


Subject(s)
Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Epidermal Growth Factor/metabolism , Genes, ras/genetics , Oncogene Protein p21(ras)/metabolism , Signal Transduction , Animals , Biotinylation , Blotting, Northern , Culture Media, Conditioned/metabolism , DNA/metabolism , DNA, Complementary/metabolism , Epiregulin , Gene Library , Humans , Ligands , Mice , Mice, Nude , Polymerase Chain Reaction , Precipitin Tests , Tetradecanoylphorbol Acetate/pharmacology , Transfection , Tumor Cells, Cultured , Up-Regulation
18.
Br J Cancer ; 80(12): 1884-91, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10471035

ABSTRACT

The urokinase receptor, overexpressed in invasive colon cancer, promotes tumour cell invasion. Since K-Ras is activated in many colon cancers, we determined if urokinase receptor overexpression is a consequence of this activated oncogene. Accordingly, urokinase receptor expression was compared in HCT 116 colon cancer cells containing either a mutation-activated K-Ras or disrupted for this oncogene (by homologous recombination). HCT 116 cells containing the disrupted K-Ras oncogene expressed between 50 and 85% less urokinase receptor protein compared with the parental HCT 116 cells. Reduced urokinase receptor expression in cells containing the disrupted mutated K-Ras was not due to a physical impairment of the urokinase receptor gene since phorbol ester treatment was inductive for its expression. Constitutive urokinase receptor expression in HCT 116 cells required an intact AP-1 motif in the promoter (at -184) and electrophoretic mobility shifting assays indicated less c-Jun, JunD, c-Fos and Fra-1 bound to this motif in the K-Ras-disrupted cells. Since the urokinase receptor accelerates proteolysis, laminin degradation was compared in cells containing the mutation-activated and disrupted K-Ras oncogene. The latter cells displaying fewer urokinase receptors, degraded 80% less laminin. This is the first study to demonstrate a role for K-Ras as a regulator of the constitutive expression of the urokinase receptor.


Subject(s)
Colonic Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Genes, ras , Plasminogen/metabolism , Receptors, Cell Surface/genetics , Cell Nucleus/metabolism , Colonic Neoplasms/metabolism , Genes, Reporter , Humans , Laminin/metabolism , Mutagenesis , Protein Biosynthesis , Receptors, Cell Surface/analysis , Receptors, Urokinase Plasminogen Activator , Transcription, Genetic , Transfection , Tumor Cells, Cultured
19.
Cancer Res ; 59(10): 2445-50, 1999 May 15.
Article in English | MEDLINE | ID: mdl-10344756

ABSTRACT

Although the frequency of activated Ki-ras genes is high in human colorectal tumors, much less is known of activated Ki-ras-mediated signaling pathways. Using gene targeting, we examined HCT116 cells that contain the Gly-13-->Asp mutation of Ki-ras and activated Ki-ras-disrupted clones derived from HCT116. 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced immediate early genes, such as c-Jun, c-Fos, and Egr-1 in activated Ki-ras-disrupted clones, whereas c-Jun induction was rare in HCT116. TPA induced both phosphorylation of stress-activated protein kinase kinase 1 (SEK1) and c-Jun NH2-terminal kinase (JNK) in the activated Ki-ras-disrupted clones but not in HCT116. On the other hand, TPA-induced mitogen-activated protein kinase kinase 1/2 (MEK1/2)-extracellular signal-regulated kinase (ERK) activation was equally induced between HCT116 and the Ki-ras-disrupted clones. Furthermore, TPA-induced SEK1-JNK activation was observed in a DLD-1-derived activated Ki-ras-disrupted clone but not in DLD-1. The TPA-induced SEK1-JNK activation in these disrupted clones was completely inhibited by the protein kinase C (PKC) inhibitor, GF109203X (1 microM), but not by another PKC inhibitor, H7 (50 microM), whereas TPA-induced MEK1/2-ERK activation was partially and completely inhibited by GF109203X (1 microM) and H7 (50 microM), respectively. A phosphoinositol 3-kinase inhibitor, LY294002, did not inhibit the TPA-induced SEK1-JNK activation. Taken together, these results suggest that activated Ki-Ras-mediated signals are involved in the SEK1-JNK pathway through a PKC isotype that is distinct from that involved in MEK1/2-ERK activation in human colon cancer cells and independent of phosphoinositol 3-kinase activation, and the imbalance between ERK and JNK activity caused by activated Ki-Ras may play critical roles in human colorectal tumorigenesis.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Colonic Neoplasms/pathology , Gene Expression Regulation, Neoplastic , Genes, ras , MAP Kinase Kinase 4 , MAP Kinase Kinase Kinase 1 , Mitogen-Activated Protein Kinase Kinases , Mitogen-Activated Protein Kinases , Neoplasm Proteins/metabolism , Protein Kinases/metabolism , Proto-Oncogene Proteins p21(ras)/physiology , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Alleles , Amino Acid Substitution , Chromones/pharmacology , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Culture Media, Serum-Free/pharmacology , Depression, Chemical , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Genes, Immediate-Early , Humans , Indoles/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/physiology , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 1 , MAP Kinase Kinase 2 , Maleimides/pharmacology , Mitogen-Activated Protein Kinase 3 , Morpholines/pharmacology , Mutation, Missense , Phosphatidylinositol 3-Kinases/physiology , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Isoforms/physiology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/physiology , Protein Processing, Post-Translational , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins p21(ras)/genetics , Tumor Cells, Cultured
20.
Proc Natl Acad Sci U S A ; 95(7): 3609-14, 1998 Mar 31.
Article in English | MEDLINE | ID: mdl-9520413

ABSTRACT

Targeted disruption of the single mutant K-ras allele in two human colorectal carcinoma cell lines (DLD-1 and HCT-116) leads to loss of tumorigenic competence in nude mice with retention of ability to grow indefinitely in monolayer culture. Because expression of the mutant K-ras oncogene in these cell lines is associated with marked up-regulation of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF), we sought to determine whether this potent angiogenesis inducer plays a role in K-ras-dependent tumorigenic competence. Transfection of a VEGF121 antisense expression vector into DLD-1 and HCT-116 cells resulted in suppression of VEGF/VPF production by a factor of 3- to 4-fold. The VEGF/VPF-deficient sublines, unlike the parental population or vector controls, were profoundly suppressed in their ability to form tumors in nude mice for as long as 6 months after cell injection. In contrast, in vitro growth of these sublines was unaffected, thus demonstrating the critical importance of VEGF/VPF as an angiogenic factor for HCT-116 and DLD-1 cells. Transfection of a full-length VEGF121 cDNA into two nontumorigenic mutant K-ras knockout sublines resulted in a weak but detectable restoration of tumorigenic ability in vivo in a subset of the transfectants, with no consistent change in growth properties in vitro. The findings indicate that mutant ras-oncogene-dependent VEGF/VPF expression is necessary, but not sufficient, for progressive tumor growth in vivo and highlight the relative contribution of oncogenes, such as mutant K-ras, to the process of tumor angiogenesis.


Subject(s)
Carcinoma/blood supply , Carcinoma/genetics , Colorectal Neoplasms/blood supply , Colorectal Neoplasms/genetics , Endothelial Growth Factors/genetics , Gene Expression Regulation, Neoplastic , Genes, ras , Lymphokines/genetics , Neovascularization, Pathologic/genetics , Animals , Humans , Mice , Mutation , Tumor Cells, Cultured , Up-Regulation , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...